HeartSciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 87.9%.

Top 15 shareholders own 16.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.32%	Mount Sinai School Of Medicine, Endowment Arm	48,549	US$129.6k	0%	0.06%
4.35%	John Matthews	39,726	US$106.1k	0%	no data
4%	John Adams	36,563	US$97.6k	0%	no data
1.11%	Hudson River Trading LLC, Asset Management Arm	10,166	US$27.1k	0%	no data
0.49%	Mark Hilz	4,457	US$11.9k	0.02%	no data
0.48%	Andrew Simpson	4,382	US$11.7k	0%	no data
0.21%	The Vanguard Group, Inc.	1,915	US$5.1k	0%	no data
0.21%	Tower Research Capital Europe Limited	1,877	US$5.0k	226%	no data
0.075%	UBS Asset Management AG	681	US$1.8k	-89.4%	no data
0.046%	Geode Capital Management, LLC	423	US$1.1k	0%	no data
0.033%	Oliver Lagore Vanvalin Investment Group, Inc.	305	US$814.2	-37.1%	no data
0.0067%	Brian Szymczak	61	US$162.9	0%	no data
0.0019%	Bruce Bent	17	US$45.4	6.25%	no data
0.00077%	Bank of America Corporation, Asset Management Arm	7	US$18.8	75%	no data
0.00011%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$2.7	0%	no data